NEW YORK (GenomeWeb News) — Prodesse said today it will stop selling three of its multiplex ASR products in the US Aug. 1 as it transitions them into in vitro diagnostics in light of a recent US Food and Drug Administration draft guidance.
 
The company said it plans to remove the underlying supermixes for its Hexaplex, Hexaplex Plus, and ProPneumo-1 products as part of an “orderly transition” from ASRs to IVD assays.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.